Your browser doesn't support javascript.
loading
Effect of CYP3A4, CYP3A5, and ABCB1 Polymorphisms on Intravenous Tacrolimus Exposure and Adverse Events in Adult Allogeneic Stem Cell Transplant Patients.
Hamadeh, Issam S; Zhang, Qing; Steuerwald, Nury; Hamilton, Alicia; Druhan, Lawrence J; McSwain, Meredith; Diez, Yordanis; Rusin, Stephanie; Han, Yimei; Symanowski, James; Gerber, Jonathan; Grunwald, Michael R; Ghosh, Nilanjan; Plesca, Dragos; Arnall, Justin; Trivedi, Jigar; Avalos, Belinda; Copelan, Edward; Patel, Jai N.
Afiliación
  • Hamadeh IS; Department of Cancer Pharmacology, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina. Electronic address: issam.hamadeh@atriumhealth.org.
  • Zhang Q; Department of Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina.
  • Steuerwald N; Molecular Biology Core Laboratory, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina.
  • Hamilton A; Molecular Biology Core Laboratory, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina.
  • Druhan LJ; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina.
  • McSwain M; Department of Pharmacy, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina.
  • Diez Y; Department of Pharmacy, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina.
  • Rusin S; Department of Pharmacy, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina.
  • Han Y; Department of Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina.
  • Symanowski J; Department of Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina.
  • Gerber J; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina.
  • Grunwald MR; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina.
  • Ghosh N; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina.
  • Plesca D; Department of Pharmacy, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina.
  • Arnall J; Department of Pharmacy, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina.
  • Trivedi J; Department of Pharmacy, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina.
  • Avalos B; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina.
  • Copelan E; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina.
  • Patel JN; Department of Cancer Pharmacology, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina. Electronic address: jai.patel@atriumhealth.org.
Biol Blood Marrow Transplant ; 25(4): 656-663, 2019 04.
Article en En | MEDLINE | ID: mdl-30597277
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Polimorfismo Genético / Tacrolimus / Trasplante de Células Madre Hematopoyéticas / Acondicionamiento Pretrasplante / Citocromo P-450 CYP3A / Inmunosupresores Tipo de estudio: Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Biol Blood Marrow Transplant Asunto de la revista: HEMATOLOGIA / TRANSPLANTE Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Polimorfismo Genético / Tacrolimus / Trasplante de Células Madre Hematopoyéticas / Acondicionamiento Pretrasplante / Citocromo P-450 CYP3A / Inmunosupresores Tipo de estudio: Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Biol Blood Marrow Transplant Asunto de la revista: HEMATOLOGIA / TRANSPLANTE Año: 2019 Tipo del documento: Article